With the rapid modernization of society, the incidence of traumatic events, including traffic accidents, industrial injuries, falls, and burn injuries has increased substantially, leading to a corresponding rise in the prevalence of chronic post-traumatic pain (CPTP). Chronic pain following trauma is predominantly neuropathic in nature, often involving central and peripheral sensitization mechanisms, and imposes a significant burden on patients' physical function, psychological well-being, sleep quality, and overall quality of life. Despite its growing clinical importance and socioeconomic impact, the diagnosis and management of CPTP remain insufficiently standardized across healthcare settings, with considerable variability in assessment tools, treatment protocols, and multidisciplinary coordination. To address this gap, the Expert Panel of the Special Capacity-Building Program for Pain Diagnosis and Treatment, organized by the National Health Commission Capacity Building and Continuing Education Center, systematically reviewed and critically appraised recent domestic and international evidence regarding the classification, prevention, diagnosis, and treatment of CPTP. High-quality evidence, including systematic reviews, meta-analyses, randomized controlled trials, clinical guidelines, and expert consensus statements, was evaluated using the GRADE methodology. Following repeated expert discussions and consensus voting, this guideline was developed to provide evidence-based, actionable recommendations for the standardized diagnosis and multidisciplinary management of CPTP. This guideline covers risk stratification, early intervention strategies, pharmacological and interventional therapies, psychological support, and rehabilitation approaches, with the ultimate aim of improving clinical practice consistency, enhancing patient outcomes, and reducing the long-term disability associated with chronic post-traumatic pain.
| Published in | International Journal of Pain Research (Volume 2, Issue 3) |
| DOI | 10.11648/j.ijpr.20260203.17 |
| Page(s) | 148-161 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2026. Published by Science Publishing Group |
Trauma, Chronic Post-traumatic Pain, Chronic Pain, Clinical Practice Guideline
Level | Strong Recommendation (1) | Weak Recommendation (2) |
|---|---|---|
High Quality (A) | In most circumstances, the recommendation applies to most patients; very confident that the estimate of effect is close to the true value | The optimal decision may vary depending on setting, patient, and societal values; very confident that the estimate of effect is close to the true value |
Moderate Quality (B) | In most circumstances, the recommendation applies to most patients; moderately confident in the estimate of effect: the estimate is likely close to the true value, but there is a possibility that it is substantially different | In some circumstances, alternative options may be better for certain patients; moderately confident in the estimate of effect: the estimate is likely close to the true value, but there is a possibility that it is substantially different |
Low Quality (C) | The recommendation may change when higher-quality evidence becomes available; limited confidence in the estimate of effect: the estimate may be substantially different from the true value | Alternative options are equally reasonable; limited confidence in the estimate of effect: the estimate may be substantially different from the true value |
Very Low Quality (D) | The recommendation may change when higher-quality evidence becomes available; very little confidence in the estimate of effect: the estimate is very likely to be substantially different from the true value | Alternative options are equally reasonable; very little confidence in the estimate of effect: the estimate is very likely to be substantially different from the true value |
Pain Type | Medication | Evidence Level | Recommendation Strength |
|---|---|---|---|
Chronic pain following peripheral nerve injury | Gabapentin [39] | A | 1 |
Mirogabalin [40, 41] | A | 1 | |
5% Lidocaine patch [42] | A | 2 | |
Bulleyaconitine A [43] | A | 1 | |
Dexamethasone palmitate [44, 45] | B | 1 | |
Chronic pain following spinal cord injury | Pregabalin [46 -52] | A | 1 |
Gabapentin [46 -49, 52] | A | 1 | |
Mirogabalin [53] | A | 1 | |
8% Capsaicin patch [54] | B | 2 | |
Botulinum toxin type A [52, 55, 56] | B | 2 | |
Intrathecal baclofen [57] | B | 2 | |
Duloxetine [52] | A | 1 | |
Chronic pain following whiplash injury | Pregabalin [58] | A | 1 |
Chronic pain after musculoskeletal injury | Loxoprofen sodium patch [59] | A | 1 |
Topical NSAIDs [60] | B | 1 | |
Acetaminophen [61] | B | 2 | |
5% Lidocaine patch [62] | B | 2 | |
Huoxue Zhitong soft capsules [63] | A | 1 | |
Xuanqi Jiangu tablets [64] | A | 1 | |
Tetrandrine tablets [65, 66] | B | 1 | |
Compound Fushang Tong capsules [67, 68] | B | 2 |
Pain Type | Physical Therapy Modality | Evidence Level | Recommendation Strength |
|---|---|---|---|
Chronic pain following peripheral nerve injury | Repetitive transcranial magnetic stimulation (rTMS) [69] | B | 2 |
Transcranial direct current stimulation (tDCS) [69] | B | 2 | |
Chronic pain following spinal cord injury | Transcutaneous electrical nerve stimulation (TENS) [70, 71] | A | 1 |
Non-invasive brain stimulation (NIBS) [72] | B | 2 | |
Transcranial electrical stimulation (TES) [73] | B | 2 | |
Repetitive transcranial magnetic stimulation (rTMS) [74] | A | 2 | |
Exercise [75, 76] | A | 1 | |
Mirror therapy [71] | B | 2 | |
Chronic pain following traumatic brain injury | Transcranial magnetic stimulation (TMS) [77] | B | 2 |
Repetitive transcranial magnetic stimulation (rTMS) [78 -80] | B | 2 | |
Hyperbaric oxygen therapy [81] | B | 1 | |
Chronic pain following whiplash injury | Specific neck exercises [82, 83] | B | 2 |
Exercise [84] | B | 2 |
Pain subtype | Intervention | Level of Evidence | Strength of Recommendation |
|---|---|---|---|
Chronic pain following peripheral nerve injury | Dorsal root ganglion (DRG) neuromodulation | B | Strong (Grade 1) |
Chronic pain following peripheral nerve injury | Peripheral nerve stimulation (PNS) | A | Strong (Grade 1) |
Chronic pain following whiplash injury | Radiofrequency neurotomy | B | Moderate (Grade 2) |
Chronic pain following whiplash injury | Nerve block | B | Strong (Grade 1) |
Pain subtype | Recommended therapy | Evidence | Recommendation |
|---|---|---|---|
Chronic pain after burn injury | Virtual reality (VR) therapy | A | Grade 2 |
Hypnosis | C | Grade 2 | |
Distraction therapy | A | Grade 2 | |
Aromatherapy | C | Grade 2 | |
Chronic pain following spinal cord injury | Virtual reality (VR) | B | Grade 1 |
Cognitive behavioral therapy (CBT) | B | Grade 1 | |
Mindfulness-based therapy | B | Grade 2 | |
Meditation and guided imagery (CMI) | B | Grade 2 | |
Music therapy | C | Grade 2 | |
Acupuncture | B | Grade 1 | |
Chronic pain following traumatic brain injury | Virtual reality (VR) | B | Grade 2 |
Acupuncture | B | Grade 1 | |
Chronic pain following whiplash injury | Cognitive behavioral intervention | B | Grade 2 |
Chronic pain after musculoskeletal injury | Hypnosis | B | Grade 2 |
Pain subtype | Surgical procedure | Evidence | Recommendation |
|---|---|---|---|
Chronic pain following peripheral nerve injury | Dorsal Root Entry Zone (DREZ) lesioning | B | Grade 2 |
Chronic pain following spinal cord injury | Dorsal Root Entry Zone (DREZ) lesioning | B | Grade 2 |
Chronic pain following whiplash injury | Cervical spinal fusion | B | Grade 2 |
ACT | Acceptance and Commitment Therapy |
CBT | Cognitive Behavioral Therapy |
CMI | Meditation and Guided Imagery |
CPABI | Chronic Pain After Burn Injury |
CPAMSI | Chronic Pain After Musculoskeletal Injury |
CPTP | Chronic Post-traumatic Pain |
CRPS | Complex Regional Pain Syndrome |
DREZ | Dorsal Root Entry Zone |
DRG | Dorsal Root Ganglion |
GRADE | Grading of Recommendations Assessment, Development and Evaluation |
ICD-11 | International Classification of Diseases, 11th Revision |
IL-1β | Interleukin-1β |
ISCIP | International Spinal Cord Injury Pain |
NIBS | Non-invasive Brain Stimulation |
NSAIDs | Non-steroidal Anti-inflammatory Drugs |
PNS | Peripheral Nerve Stimulation |
PTSD | Post-traumatic Stress Disorder |
RCTs | Randomized Controlled Trials |
rTMS | Repetitive Transcranial Magnetic Stimulation |
SCI | Spinal Cord Injury |
TBI | Traumatic Brain Injury |
tDCS | Transcranial Direct Current Stimulation |
TENS | Transcutaneous Electrical Nerve Stimulation |
TES | Transcranial Electrical Stimulation |
TMJ | Temporomandibular Joint |
TMS | Transcranial Magnetic Stimulation |
TNF-α | Tumor Necrosis Factor-α |
VR | Virtual Reality |
| [1] | Schug SA, Lavand'homme P, Barke A, et al. IASP taskforce for the classification of chronic pain. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain [J]. Pain, 2019, 160(1): 45-52. |
| [2] | Xing D, Yu NS, Zhang CQ. Interpretation and methodological evaluation of the recommendations in the "Clinical Practice Guideline for the Treatment of Knee Osteoarthritis with Intra-articular Injection of Platelet-Rich Plasma (2018 Edition)" [J]. Chinese Journal of Joint Surgery (Electronic Edition), 2018, 12(4): 6-10. |
| [3] | Moldovan M, Alvarez S, Romer Rosberg M, et al. Axonal voltage-gated ion channels as pharmacological targets for pain [J]. Eur J Pharmacol, 2013, 708(1-3): 105-112. |
| [4] | Kuner R, Flor H. Structural plasticity and reorganisation in chronic pain [J]. Nat Rev Neurosci, 2016, 18(1): 20-30. |
| [5] | Liu Y, Zhou LJ, Wang J, et al. TNF-α differentially regulates synaptic plasticity in the hippocampus and spinal cord by microglia-dependent mechanisms after peripheral nerve injury [J]. J Neurosci, 2017, 37(4): 871-881. |
| [6] | Ossipov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain [J]. Curr Opin Support Palliat Care, 2014, 8(2): 143-151. |
| [7] | Ong WY, Stohler CS, Herr DR. Role of the prefrontal cortex in pain processing [J]. Mol Neurobiol, 2019, 56(2): 1137-1166. |
| [8] | Liu XG. Normalization of neuroinflammation: a new strategy for treatment of persistent pain and memory/emotional deficits in chronic pain [J]. J Inflamm Res, 2022, 15: 5201-5233. |
| [9] | Editorial Board of the Chinese Journal of Burns. Guidelines for pain management in adult burn patients (2013 Edition) [J]. Chinese Journal of Burns, 2013, 29(3): 225-231. |
| [10] | Feng Y, Xu JJ, Lin XQ, et al. Chronic postsurgical or posttraumatic pain [J]. Chinese Journal of Pain Medicine, 2021, 27(4): 241-245. |
| [11] | Klifto KM, Hultman CS, Dellon AL. Nerve pain after burn injury: a proposed etiology-based classification [J]. Plast Reconstr Surg, 2021, 147(3): 635-644. |
| [12] | Liu LB, Zhong YH. Research progress on influencing factors of chronic pain after burns [J]. Journal of Nurses Training, 2021, 36(21): 1958-1961. |
| [13] | Wang ML, Rivlin M, Graham JG, et al. Peripheral nerve injury, scarring, and recovery [J]. Connect Tissue Res, 2019, 60(1): 3-9. |
| [14] | Scholz J, Finnerup NB, Attal N, et al. Classification committee of the neuropathic pain special interest group (neuPSIG), the IASP classification of chronic pain for ICD-11: chronic neuropathic pain [J]. Pain, 2019, 160(1): 53-59. |
| [15] | Aziguli Aji, Wu ZY, Chen X, et al. Correlation between painful neuropathy and peripheral nerve conduction velocity in patients with type 2 diabetes mellitus [J]. Chinese Journal of Pain Medicine, 2023, 29(3): 219-225. |
| [16] | Bouhassira D. Neuropathic pain: definition, assessment and epidemiology [J]. Rev Neurol (Paris), 2019, 175(1-2): 16-25. |
| [17] | Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances [J]. Lancet, 2021, 397(10289): 2082-2097. |
| [18] | Dijkers MP, Bryce TN. Introducing the international spinal cord injury pain (ISCIP) classification [J]. Pain Manag, 2012, 2(4): 311-314. |
| [19] | Zhao HX, Zhang JR. Discussion on the classification of pain after spinal cord injury [J]. Chinese Journal of Rehabilitation, 2015(3): 225-228. |
| [20] | Siddall PJ, McClelland JM, Rutkowski SB, et al. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury [J]. Pain, 2003, 103(3): 249-257. |
| [21] | Hunt C, Moman R, Peterson A, et al. Prevalence of chronic pain after spinal cord injury: a systematic review and meta-analysis [J]. Reg Anesth Pain Med, 2021, 46(4): 328-336. |
| [22] | Hatch MN, Cushing TR, Carlson GD, et al. Neuropathic pain and SCI: identification and treatment strategies in the 21st century [J]. J Neurol Sci, 2018, 384: 75-83. |
| [23] | Majedi H, Safdarian M, Hajiaghahbaei M, et al. Characteristics of neuropathic pain in individuals with chronic spinal cord injury [J]. Neurosciences (Riyadh), 2018, 23(4): 292-300. |
| [24] | Rosner J, Negraff M, Belanger LM, et al. Characterization of hyperacute neuropathic pain after spinal cord injury: a prospective study [J]. J Pain, 2022, 23(1): 89-97. |
| [25] | Grandhi R, Tavakoli S, Ortega C, et al. A review of chronic pain and cognitive, mood, and motor dysfunction following mild traumatic brain injury: complex, comorbid, and/or overlapping conditions? [J]. Brain Sci, 2017, 7(12): 160. |
| [26] | Robayo LE, Govind V, Vastano R, et al. Multidimensional pain phenotypes after traumatic brain injury [J]. Front Pain Res (Lausanne), 2022, 3: 947562. |
| [27] | Leung A. Addressing chronic persistent headaches after MTBI as a neuropathic pain state [J]. J Headache Pain, 2020, 21(1): 77. |
| [28] | Ashina H, Iljazi A, Al-Khazali HM, et al. Persistent post-traumatic headache attributed to mild traumatic brain injury: deep phenotyping and treatment patterns [J]. Cephalalgia, 2020, 40(6): 554-564. |
| [29] | O'Neil ME, Carlson KF, Holmer HK, et al. Chronic pain in veterans and servicemembers with a history of mild traumatic brain injury: a systematic review [Internet]. Washington (DC): Department of Veterans Affairs (US), 2020. |
| [30] | Park AL, Hwang EH, Hwang MS, et al. Cost-effectiveness of Chuna Manual Therapy and usual care, compared with usual care only for people with neck pain following traffic accidents: a multicenter randomized controlled trial [J]. Int J Environ Res Public Health, 2021, 18(19): 9994. |
| [31] | Qiu H, Suo FJ, Cao CF, et al. Research progress of whiplash injury [J]. Journal of Cervicodynia and Lumbodynia, 2015, 36(6): 508-510. |
| [32] | Cooper G, Bailey B, Bogduk N. Cervical zygapophysial joint pain maps [J]. Pain Med, 2007, 8(4): 344-353. |
| [33] | Bogduk N. On cervical zygapophysial joint pain after whiplash [J]. Spine (Phila Pa 1976), 2011, 36(25 Suppl): S194-199. |
| [34] | Friesgaard KD, Gromov K, Knudsen LF, et al. Persistent pain is common 1 year after ankle and wrist fracture surgery: a register-based questionnaire study [J]. Br J Anaesth, 2016, 116(5): 655-661. |
| [35] | Pierik JG, IJzerman MJ, Gaakeer MI, et al. Incidence and prognostic factors of chronic pain after isolated musculoskeletal extremity injury [J]. Eur J Pain, 2016, 20(5): 711-722. |
| [36] | Alkassabi O, Voogt L, Andrews P, et al. Risk factors to persistent pain following musculoskeletal injuries: a systematic literature review [J]. Int J Environ Res Public Health, 2022, 19(15): 9318. |
| [37] | El-Tallaay SN, Nalamasu R, Salem GI, et al. Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain [J]. Pain Ther, 2021, 10(1): 181-209. |
| [38] | Zhao Y, Zhang H, Li N, et al. Chronic pain after bone fracture: Current insights into molecular mechanisms and therapeutic strategies [J]. Brain Sci, 2022, 12(8): 1056. |
| [39] | Gordh TE, Stubhaug A, Jensen TS, et al. Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study [J]. Pain, 2008, 138(2): 255-266. |
| [40] | Kimura Y, Yamaguchi S, Suzuki T, et al. Switching from pregabalin to mirogabalin in patients with peripheral neuropathic pain: a multi-center, prospective, single-arm, open-label study (MIROP Study) [J]. Pain Ther, 2021, 10(1): 711-727. |
| [41] | Nikaido T, Takatsuna H, Tabata S, et al. Efficacy and safety of add-on mirogabalin to NSAIDs in lumbar spinal stenosis with peripheral neuropathic pain: a randomized, open-label study [J]. Pain Ther, 2022, 11(4): 1195-1214. |
| [42] | Correa-Illanes G, Roa R, Piñeros JL, et al. Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves [J]. Local Reg Anesth, 2012, 5: 47-53. |
| [43] | Xiao H, Ma K, Huang D, et al. Expert consensus of the Chinese Association for the Study of Pain on the clinical use of bulleyaconitine A [J]. Pain Ther, 2022, 11(4): 1121-1137. |
| [44] | Chinese Society of Pain Medicine, Chinese Medical Association. Expert consensus on the use of dexamethasone palmitate for peripheral neuropathic pain [J]. National Medical Journal of China, 2019, 99(15): 1133-1137. |
| [45] | Qiao CF, Yang ZL, Chen JT, et al. Clinical study of epidural injection of dexamethasone palmitate for cervical radiculopathy [J]. Journal of Practical Painology, 2013, 9(2): 109-112. |
| [46] | Davari M, Amani B, Amani B, et al. Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis [J]. Korean J Pain, 2020, 33(1): 3-12. |
| [47] | Asgardoon MH, Jazayeri SB, Behkara A, et al. Pharmacologic therapies of pain in patients with spinal cord injury: a systematic review [J]. Spinal Cord Ser Cases, 2022, 8(1): 65. |
| [48] | Tong C, Zhengyao Z, Mei L, et al. Pregabalin and gabapentin in patients with spinal cord injury-related neuropathic pain: a network meta-analysis [J]. Pain Ther, 2021, 10(2): 1497-1509. |
| [49] | Mei L, Fengqun M, Zhengyao Z, et al. Efficacy and safety of different drug treatments in patients with spinal-cord injury-related neuropathic pain: a network meta-analysis [J]. Spinal Cord, 2022, 60(11): 943-953. |
| [50] | Onakpoya IJ, Thomas ET, Lee JJ, et al. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials [J]. BMJ Open, 2019, 9(1): e023600. |
| [51] | Canavan C, Inoue T, McMahon S, et al. The efficacy, adverse events, and withdrawal rates of the pharmacological management of chronic spinal cord injury pain: a systematic review and meta-analysis [J]. Pain Med, 2022, 23(2): 375-395. |
| [52] | Ling HQ, Chen ZH, He L, et al. Comparative efficacy and safety of 11 drugs as therapies for adults with neuropathic pain after spinal cord injury: a Bayesian network analysis based on 20 randomized controlled trials [J]. Front Neurol, 2022, 13: 818522. |
| [53] | Ushida T, Katayama Y, Hiasa Y, et al. Mirogabalin for central neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled, phase 3 study in Asia [J]. Neurology, 2023, 100(11): e1193-e1206. |
| [54] | Olusanya A, Yearsley A, Brown N, et al. Capsaicin 8% patch for spinal cord injury focal neuropathic pain, a randomized controlled trial [J]. Pain Med, 2023, 24(1): 71-78. |
| [55] | Han ZA, Song DH, Oh HM, et al. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury [J]. Ann Neurol, 2016, 79(4): 569-578. |
| [56] | Li G, Lv CA, Tian L, et al. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury [J]. Medicine (Baltimore), 2017, 96(20): e6919. |
| [57] | Kumru H, Benito-Penalva J, Kofler M, et al. Analgesic effect of intrathecal baclofen bolus on neuropathic pain in spinal cord injury patients [J]. Brain Res Bull, 2018, 140: 205-211. |
| [58] | Nikles J, Keijzers G, Mitchell G, et al. Pregabalin vs placebo to prevent chronic pain after whiplash injury in at-risk individuals: results of a feasibility study for a large randomised controlled trial [J]. Pain, 2022, 163(2): e274-e284. |
| [59] | Zhao D, Chen Z, Hu S, et al. Efficacy and safety of loxoprofen hydrogel transdermal patch versus loxoprofen tablet in Chinese patients with myalgia: a double-blind, double-dummy, parallel-group, randomized, controlled, non-inferiority trial [J]. Clin Drug Investig, 2019, 39(4): 369-377. |
| [60] | Shi C, Ye Z, Shao Z, et al. Multidisciplinary guidelines for the rational use of topical non-steroidal anti-inflammatory drugs for musculoskeletal pain (2022) [J]. J Clin Med, 2023, 12(4): 1544. |
| [61] | Freo U, Ruocco C, Valerio A, et al. Paracetamol: a review of guideline recommendations [J]. J Clin Med, 2021, 10(15): 3420. |
| [62] | Hans G, Joukes E, Verhulst J, et al. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases [J]. Curr Med Res Opin, 2009, 25(11): 2737-2743. |
| [63] | Shi GY, Zhang WA, Dong JW, et al. Multicenter clinical study of Huoxue Zhitong soft capsules in the treatment of chronic soft tissue injury (qi stagnation and blood stasis syndrome) [J]. China's Naturopathy, 2018, 26(13): 30-32. |
| [64] |
National Medical Products Administration. 2021 Annual Drug Evaluation Report [EB/OL]. (2022-06-01):
https://www.nmpa.gov.cn/xxgk/lfwj/gzwj/gzwjyp/20220601110541120.html |
| [65] | Chinese Aging Well Association. Expert consensus on the diagnosis and treatment of chronic musculoskeletal pain [J]. Orthopedics, 2021, 12(5): 389-395. |
| [66] | Wei W, Zhu YJ, Gao GD. A controlled study on efficacy and safety of tetrandrine tablets combined with diclofenac sodium tablets in the treatment of osteoarthritis [J]. Chinese Journal of Primary Medicine and Pharmacy, 2018, 25(13): 1724-1728. |
| [67] | Li D, Dong XJ, Cheng H, et al. Treatment of 35 cases of traumatic knee synovitis with Compound Fushangtong Capsules [J]. Chinese Journal of Traditional Medical Traumatology & Orthopedics, 2016, 24(9): 22-24. |
| [68] | Zhang ZC, Mao DR, Zhang LL. Clinical observation of Compound Fushangtong Capsules in promoting fracture healing [J]. Contemporary Medicine, 2018, 24(4): 29-31. |
| [69] | Bonifacio de Assis ED, Martins WKN, de Carvalho CD, et al. Effects of rTMS and tDCS on neuropathic pain after brachial plexus injury: a randomized placebo-controlled pilot study [J]. Sci Rep, 2022, 12(1): 1440. |
| [70] | Yang Y, Tang Y, Qin H, et al. Efficacy of transcutaneous electrical nerve stimulation in people with pain after spinal cord injury: a meta-analysis [J]. Spinal Cord, 2022, 60(5): 375-381. |
| [71] | Kannan P, Bello UM, Winser SJ. Physiotherapy interventions may relieve pain in individuals with central neuropathic pain: a systematic review and meta-analysis of randomised controlled trials [J]. Ther Adv Chronic Dis, 2022, 13: 20406223221078672. |
| [72] | Li L, Huang H, Yu Y, et al. Non-invasive brain stimulation for neuropathic pain after spinal cord injury: a systematic review and network meta-analysis [J]. Front Neurosci, 2022, 15: 800560. |
| [73] | Mehta S, Orenczuk K, McIntyre A, et al. Neuropathic pain post spinal cord injury part 1: systematic review of physical and behavioral treatment [J]. Top Spinal Cord Inj Rehabil, 2013, 19(1): 61-77. |
| [74] | Saleh C, Ilia TS, Jaszczuk P, et al. Is transcranial magnetic stimulation as treatment for neuropathic pain in patients with spinal cord injury efficient? A systematic review [J]. Neurol Sci, 2022, 43(5): 3007-3018. |
| [75] | Todd KR, Lawrason SVC, Shaw RB, et al. Physical activity interventions, chronic pain, and subjective well-being among persons with spinal cord injury: a systematic scoping review [J]. Spinal Cord, 2021, 59(2): 93-104. |
| [76] | Zhang YH, Hu HY, Xiong YC, et al. Exercise for neuropathic pain: a systematic review and expert consensus [J]. Front Med (Lausanne), 2021, 8: 756940. |
| [77] | Leung A, Shirvankar P, Chen R, et al. Transcranial magnetic stimulation for pain, headache, and comorbid depression: INS-NANS expert consensus panel review and recommendation [J]. Neuromodulation, 2020, 23(3): 267-290. |
| [78] | Li X, Lu T, Yu H, et al. Repetitive transcranial magnetic stimulation for neuropathic pain and neuropsychiatric symptoms in traumatic brain injury: a systematic review and meta-analysis [J]. Neural Plast, 2022, 2022: 2036736. |
| [79] | Choi GS, Kwak SG, Lee HD, et al. Effect of high-frequency repetitive transcranial magnetic stimulation on chronic central pain after mild traumatic brain injury: a pilot study [J]. J Rehabil Med, 2018, 50(3): 246-252. |
| [80] | Leung A, Shukla S, Fallah A, et al. Repetitive transcranial magnetic stimulation in managing mild traumatic brain injury-related headaches [J]. Neuromodulation, 2016, 19(2): 133-141. |
| [81] | Ablin JN, Lang E, Catalogna M, et al. Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: a randomized, controlled trial [J]. PLoS One, 2023, 18(3): e0282406. |
| [82] | Landén Ludvigsson M, Peterson G, Peolsson A. Neck-specific exercise may reduce radiating pain and signs of neurological deficits in chronic whiplash - analyses of a randomized clinical trial [J]. Sci Rep, 2018, 8(1): 12409. |
| [83] | Ludvigsson ML, Peterson G, Peolsson A. Neck-specific exercise for radiating pain and neurological deficits in chronic whiplash, a 1-year follow-up of a randomised clinical trial [J]. Sci Rep, 2020, 10(1): 6758. |
| [84] | Chrcanovic B, Larsson J, Malmström EM, et al. Exercise therapy for whiplash-associated disorders: a systematic review and meta-analysis [J]. Scand J Pain, 2021, 22(2): 232-261. |
| [85] | Kretzschmar M, Reining M, Schwarz MA. Three-year outcomes after dorsal root ganglion stimulation in the treatment of neuropathic pain after peripheral nerve injury of upper and lower extremities [J]. Neuromodulation, 2021, 24(4): 700-707. |
| [86] | Helm S, Shirsat N, Calodney A, et al. Peripheral nerve stimulation for chronic pain: a systematic review of effectiveness and safety [J]. Pain Ther, 2021, 10(2): 985-1002. |
| [87] | Curatolo M. Pharmacological and interventional management of pain after whiplash injury [J]. J Orthop Sports Phys Ther, 2016, 46(10): 845-850. |
| [88] | Lord SM, Barnsley L, Wallis BJ, et al. Chronic cervical zygapophysial joint pain after whiplash. A placebo-controlled prevalence study [J]. Spine (Phila Pa 1976), 1996, 21(15): 1737-1744; discussion 1744-1745. |
| [89] | Gillum M, Huang S, Kuromaru Y, et al. Nonpharmacologic management of procedural pain in pediatric burn patients: a systematic review of randomized controlled trials [J]. J Burn Care Res, 2022, 43(2): 368-373. |
| [90] | Garrido-Ardila EM, Santos-Domínguez M, Rodríguez-Mansilla J, et al. A systematic review of the effectiveness of virtual reality-based interventions on pain and range of joint movement associated with burn injuries [J]. J Pers Med, 2022, 12(8): 1269. |
| [91] | Norouzkhani N, Chaghian Arani R, Mehrabi H, et al. Effect of virtual reality-based interventions on pain during wound care in burn patients; a systematic review and meta-analysis [J]. Arch Acad Emerg Med, 2022, 10(1): e84. |
| [92] | Provençal SC, Bond S, Rizkallah E, et al. Hypnosis for burn wound care pain and anxiety: a systematic review and meta-analysis [J]. Burns, 2018, 44(8): 1870-1881. |
| [93] | Ma HZ, Zhang J, Yao M, et al. Effects of aromatherapy on pain, anxiety and sleep in adult burn patients: a meta-analysis [J]. Chinese Evidence-Based Nursing, 2022, 8(24): 3303-3307. |
| [94] | Chi B, Chau B, Yeo E, et al. Virtual reality for spinal cord injury-associated neuropathic pain: systematic review [J]. Ann Phys Rehabil Med, 2019, 62(1): 49-57. |
| [95] | Tran Y, Austin P, Lo C, et al. An exploratory EEG analysis on the effects of virtual reality in people with neuropathic pain following spinal cord injury [J]. Sensors (Basel), 2022, 22(7): 2629. |
| [96] | Burke D, Lennon O, Blake C, et al. An internet-delivered cognitive behavioural therapy pain management programme for spinal cord injury pain: a randomized controlled trial [J]. Eur J Pain, 2019, 23(7): 1264-1282. |
| [97] | Hearn JH, Cross A. Mindfulness for pain, depression, anxiety, and quality of life in people with spinal cord injury: a systematic review [J]. BMC Neurol, 2020, 20(1): 32. |
| [98] | Hearn JH, Finlay KA. Internet-delivered mindfulness for people with depression and chronic pain following spinal cord injury: a randomized, controlled feasibility trial [J]. Spinal Cord, 2018, 56(8): 750-761. |
| [99] | Zanca JM, Gilchrist C, Ortiz CE, et al. Pilot clinical trial of a clinical meditation and imagery intervention for chronic pain after spinal cord injury [J]. J Spinal Cord Med, 2022, 45(3): 339-353. |
| [100] | Wood C, Cutshall SM, Lawson DK, et al. Music therapy for anxiety and pain after spinal cord injury: a pilot study [J]. Glob Adv Health Med, 2021, 10: 21649561211058697. |
| [101] | He K, Hu R, Huang Y, et al. Effects of acupuncture on neuropathic pain induced by spinal cord injury: a systematic review and meta-analysis [J]. Evid Based Complement Alternat Med, 2022, 2022: 6297484. |
| [102] | Varma A, Naqvi WM, Mulla S, et al. A systematic review of randomized controlled trials on virtual reality application in pediatric patients [J]. Cureus, 2022, 14(10): e30543. |
| [103] | Sodders MD, Martin AM, Coker J, et al. Acupuncture use for pain after traumatic brain injury: a NIDILRR traumatic brain injury model systems cohort study [J]. Brain Inj, 2023, 37(6): 494-502. |
| [104] | Andersen TE, Ravn SL, Mejldal A, et al. Values-based cognitive behavioural therapy for the prevention of chronic whiplash associated disorders: a randomized controlled trial [J]. Eur J Pain, 2022, 26(6): 1256-1268. |
| [105] | Langlois P, Perrochon A, David R, et al. Hypnosis to manage musculoskeletal and neuropathic chronic pain: a systematic review and meta-analysis [J]. Neurosci Biobehav Rev, 2022, 135: 104591. |
| [106] | Liu RC, Ni B, Hu YS, et al. Efficacy and influencing factors of dorsal root entry zone lesioning for neuropathic pain after brachial plexus injury: a report of 105 cases [J]. Chinese Journal of Neurosurgery, 2020, 36(4): 385-389. |
| [107] | Mehta S, Orenczuk K, McIntyre A, et al. Neuropathic pain post spinal cord injury part 2: systematic review of dorsal root entry zone procedure [J]. Top Spinal Cord Inj Rehabil, 2013, 19(1): 78-86. |
| [108] | Nystrom B, Svensson E, Larsson S, et al. A small group Whiplash-Associated-Disorders (WAD) patiets with central neck pain and movement induced stabbing pain, the painful segment determined by mechanical provocation: fusion surgery was superior to multimodal rehabilitation in a randomized trial [J]. Scand J Pain, 2016, 12: 33-42. |
APA Style
Lyu, Y., Cheng, Z., Liu, X., Liu, Q., Liu, J., et al. (2026). A Chinese Guideline for the Diagnosis and Management of Chronic Post-Traumatic Pain (2023 Edition). International Journal of Pain Research, 2(3), 148-161. https://doi.org/10.11648/j.ijpr.20260203.17
ACS Style
Lyu, Y.; Cheng, Z.; Liu, X.; Liu, Q.; Liu, J., et al. A Chinese Guideline for the Diagnosis and Management of Chronic Post-Traumatic Pain (2023 Edition). . 2026, 2(3), 148-161. doi: 10.11648/j.ijpr.20260203.17
@article{10.11648/j.ijpr.20260203.17,
author = {Yan Lyu and Zhixiang Cheng and Xianguo Liu and Qing Liu and Jinfeng Liu and Xiaoqiu Yang and Suoliang Wang and Lin Wang and Zhigang Zhuang and Cunwei Shi and Yanhua Li and Ying Zhang and Wei Tao and Yanqing Liu},
title = {A Chinese Guideline for the Diagnosis and Management of Chronic Post-Traumatic Pain (2023 Edition)},
journal = {International Journal of Pain Research},
volume = {2},
number = {3},
pages = {148-161},
doi = {10.11648/j.ijpr.20260203.17},
url = {https://doi.org/10.11648/j.ijpr.20260203.17},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijpr.20260203.17},
abstract = {With the rapid modernization of society, the incidence of traumatic events, including traffic accidents, industrial injuries, falls, and burn injuries has increased substantially, leading to a corresponding rise in the prevalence of chronic post-traumatic pain (CPTP). Chronic pain following trauma is predominantly neuropathic in nature, often involving central and peripheral sensitization mechanisms, and imposes a significant burden on patients' physical function, psychological well-being, sleep quality, and overall quality of life. Despite its growing clinical importance and socioeconomic impact, the diagnosis and management of CPTP remain insufficiently standardized across healthcare settings, with considerable variability in assessment tools, treatment protocols, and multidisciplinary coordination. To address this gap, the Expert Panel of the Special Capacity-Building Program for Pain Diagnosis and Treatment, organized by the National Health Commission Capacity Building and Continuing Education Center, systematically reviewed and critically appraised recent domestic and international evidence regarding the classification, prevention, diagnosis, and treatment of CPTP. High-quality evidence, including systematic reviews, meta-analyses, randomized controlled trials, clinical guidelines, and expert consensus statements, was evaluated using the GRADE methodology. Following repeated expert discussions and consensus voting, this guideline was developed to provide evidence-based, actionable recommendations for the standardized diagnosis and multidisciplinary management of CPTP. This guideline covers risk stratification, early intervention strategies, pharmacological and interventional therapies, psychological support, and rehabilitation approaches, with the ultimate aim of improving clinical practice consistency, enhancing patient outcomes, and reducing the long-term disability associated with chronic post-traumatic pain.},
year = {2026}
}
TY - JOUR T1 - A Chinese Guideline for the Diagnosis and Management of Chronic Post-Traumatic Pain (2023 Edition) AU - Yan Lyu AU - Zhixiang Cheng AU - Xianguo Liu AU - Qing Liu AU - Jinfeng Liu AU - Xiaoqiu Yang AU - Suoliang Wang AU - Lin Wang AU - Zhigang Zhuang AU - Cunwei Shi AU - Yanhua Li AU - Ying Zhang AU - Wei Tao AU - Yanqing Liu Y1 - 2026/09/09 PY - 2026 N1 - https://doi.org/10.11648/j.ijpr.20260203.17 DO - 10.11648/j.ijpr.20260203.17 T2 - International Journal of Pain Research JF - International Journal of Pain Research JO - International Journal of Pain Research SP - 148 EP - 161 PB - Science Publishing Group SN - 3070-1562 UR - https://doi.org/10.11648/j.ijpr.20260203.17 AB - With the rapid modernization of society, the incidence of traumatic events, including traffic accidents, industrial injuries, falls, and burn injuries has increased substantially, leading to a corresponding rise in the prevalence of chronic post-traumatic pain (CPTP). Chronic pain following trauma is predominantly neuropathic in nature, often involving central and peripheral sensitization mechanisms, and imposes a significant burden on patients' physical function, psychological well-being, sleep quality, and overall quality of life. Despite its growing clinical importance and socioeconomic impact, the diagnosis and management of CPTP remain insufficiently standardized across healthcare settings, with considerable variability in assessment tools, treatment protocols, and multidisciplinary coordination. To address this gap, the Expert Panel of the Special Capacity-Building Program for Pain Diagnosis and Treatment, organized by the National Health Commission Capacity Building and Continuing Education Center, systematically reviewed and critically appraised recent domestic and international evidence regarding the classification, prevention, diagnosis, and treatment of CPTP. High-quality evidence, including systematic reviews, meta-analyses, randomized controlled trials, clinical guidelines, and expert consensus statements, was evaluated using the GRADE methodology. Following repeated expert discussions and consensus voting, this guideline was developed to provide evidence-based, actionable recommendations for the standardized diagnosis and multidisciplinary management of CPTP. This guideline covers risk stratification, early intervention strategies, pharmacological and interventional therapies, psychological support, and rehabilitation approaches, with the ultimate aim of improving clinical practice consistency, enhancing patient outcomes, and reducing the long-term disability associated with chronic post-traumatic pain. VL - 2 IS - 3 ER -